DIA
PBYI icon

Denver Investment Advisors’s Puma Biotechnology PBYI Stock Holding History

Denver Investment Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-19,467
Closed -$4.6M – 598
2015
Q1 		$4.6M Buy
19,467
+9,535
+96% +$2.04M 0.15% 161
2014
Q4 		$1.88M Buy
9,932
+138
+1% +$30.6K 0.06% 283
2014
Q3 		$2.34M Buy
+9,794
New +$2.01M 0.08% 258
2014
Q1 		– Sell
-15,601
Closed -$1.61M – 653
2013
Q4 		$1.61M Sell
15,601
-8,586
-35% -$504K 0.05% 335
2013
Q3 		$1.3M Buy
+24,187
New +$1.3M 0.03% 377

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Denver Investment Advisors's PBYI Position: Q2 2015 in Review

Denver Investment Advisors sold out of Puma Biotechnology (PBYI) in Q2 2015, closing a stake of 19,467 shares — an estimated $4.6M sold.

Denver Investment Advisors first reported a position in PBYI in Q3 2013 and held it in 5 quarters. The position peaked at $4.6M in Q1 2015. 198 funds tracked by Wall St. Rank hold PBYI as of Q2 2015.

  • Denver Investment Advisors reported no remaining Puma Biotechnology position as of Q2 2015 after selling out during the quarter.
  • Denver Investment Advisors sold 19,467 Puma Biotechnology shares in Q2 2015, an estimated $4.6M.
  • Denver Investment Advisors first reported a position in Puma Biotechnology in Q3 2013 and held it in 5 quarters.
  • Denver Investment Advisors's Puma Biotechnology position peaked at $4.6M in Q1 2015.
  • 198 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2015.

Based on Denver Investment Advisors's 13F filing for Q2 2015, filed 10 Aug 2015.